BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Prognosis
68 results:

  • 1. TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to MYH9.
    Hu R; Cao Y; Wang Y; Zhao T; Yang K; Fan M; Guan M; Hou Y; Ying J; Ma X; Deng N; Sun X; Zhang Y; Zhang X
    Breast Cancer Res; 2024 Mar; 26(1):48. PubMed ID: 38504374
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Efficacy of adding levofloxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patients with advanced pancreatic cancer: study protocol for a multicenter, randomized phase 2 trial (T-CORE2201).
    Imai H; Sakamoto Y; Takahashi S; Shibata H; Sato A; Otsuka K; Amagai K; Takahashi M; Yamaguchi T; Ishioka C
    BMC Cancer; 2024 Feb; 24(1):262. PubMed ID: 38402399
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells.
    Tassi E; Bergamini A; Wignall J; Sant'Angelo M; Brunetto E; Balestrieri C; Redegalli M; Potenza A; Abbati D; Manfredi F; Cangi MG; Magliacane G; Scalisi F; Ruggiero E; Maffia MC; Trippitelli F; Rabaiotti E; Cioffi R; Bocciolone L; Candotti G; Candiani M; Taccagni G; Schultes B; Doglioni C; Mangili G; Bonini C
    Front Immunol; 2023; 14():1212444. PubMed ID: 37868997
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identification of Diagnostic Metabolic Signatures in Thyroid Tumors Using Mass Spectrometry Imaging.
    Mao X; Huang L; Li T; Abliz Z; He J; Chen J
    Molecules; 2023 Jul; 28(15):. PubMed ID: 37570761
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Multikinase Inhibitors for the Treatment of Asymptomatic Radioactive Iodine-Refractory Differentiated Thyroid cancer: Global Noninterventional Study (RIFTOS MKI).
    Brose MS; Smit JWA; Lin CC; Tori M; Bowles DW; Worden F; Shen DH; Huang SM; Tsai HJ; Alevizaki M; Peeters RP; Takahashi S; Rumyantsev P; Guan R; Babajanyan S; Ozgurdal K; Sugitani I; Pitoia F; Lamartina L
    Thyroid; 2022 Sep; 32(9):1059-1068. PubMed ID: 35950621
    [No Abstract]    [Full Text] [Related]  

  • 6. NOD1 activation promotes cell apoptosis in papillary thyroid cancer.
    Bai N; Liu C; Zhang X; Cheng Y; Hou D
    Pathol Res Pract; 2022 May; 233():153880. PubMed ID: 35430507
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Comparison of clinical characteristics between sporadic gastrinoma and multiple endocrine neoplasia type 1-related gastrinoma].
    Guo Y; Chen LH; Liu M; Zhang YX; Zhang N; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):875-882. PubMed ID: 34674462
    [No Abstract]    [Full Text] [Related]  

  • 8. Impact of incomplete surgery and adjuvant chemotherapy for the intraoperative rupture of capsulated stage I epithelial ovarian cancer: a multi-institutional study with an in-depth subgroup analysis.
    Yoshihara M; Tamauchi S; Iyoshi S; Kitami K; Uno K; Mogi K; Kajiyama H
    J Gynecol Oncol; 2021 Sep; 32(5):e66. PubMed ID: 34378361
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Nationwide population-based study of prevalence and trend of borderline ovarian tumors in the Republic of Korea.
    Ouh YT; Kang D; Kim H; Lee JK; Hong JH
    Sci Rep; 2021 May; 11(1):11158. PubMed ID: 34045639
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinical characteristics and treatment analysis of pancreatic acinar cell carcinoma: A single institutional comparison to pancreatic ductal adenocarcinoma.
    Huang X; Li M; Zhang L; Xiong J; Lu H; Tian B
    Surg Oncol; 2021 Jun; 37():101528. PubMed ID: 33611029
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Pathological characteristics and survival analysis of 355 patients with gastroenteropancreatic neuroendocrine neoplasms].
    Li Y; Wang YF; Tan BB; Er LM; Zhao Q; Fan LQ; Zhang ZD; Liu Y
    Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):426-431. PubMed ID: 32482035
    [No Abstract]    [Full Text] [Related]  

  • 12. PD-L1 and thyroid cytology: A possible diagnostic and prognostic marker.
    Dell'Aquila M; Granitto A; Martini M; Capodimonti S; Cocomazzi A; Musarra T; Fiorentino V; Pontecorvi A; Lombardi CP; Fadda G; Pantanowitz L; Larocca LM; Rossi ED
    Cancer Cytopathol; 2020 Mar; 128(3):177-189. PubMed ID: 31821747
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Clinicopathological features and prognosis of 488 patients with neuroendocrine tumors].
    Zhai XJ; Yu SL; Ma YH; Wang F; Yang MJ; Lian YJ; Yu XX; Fan QX; Song LJ
    Zhonghua Yi Xue Za Zhi; 2019 Aug; 99(32):2527-2531. PubMed ID: 31484281
    [No Abstract]    [Full Text] [Related]  

  • 14. Percutaneous radiofrequency ablation of adrenal metastases from hepatocellular carcinoma: a single-center experience.
    Huang J; Xie X; Lin J; Wang W; Zhang X; Liu M; Li X; Huang G; Liu B; Xie X
    Cancer Imaging; 2019 Jun; 19(1):44. PubMed ID: 31242934
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Cystic pancreatic neuroendocrine tumors: A distinctive subgroup with indolent biological behavior? A systematic review and meta-analysis.
    Zhu JK; Wu D; Xu JW; Huang X; Jiang YY; Edil BH; Li M; Hu SY; Zhan HX
    Pancreatology; 2019 Jul; 19(5):738-750. PubMed ID: 31160191
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. In-Depth Proteomics Analysis to Identify Biomarkers of Papillary Thyroid cancer Patients Older Than 45 Years with Different Degrees of Lymph Node Metastases.
    Zhan S; Wang T; Wang M; Li J; Ge W
    Proteomics Clin Appl; 2019 Sep; 13(5):e1900030. PubMed ID: 31148369
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Upregulation of the solute carrier family 7 genes is indicative of poor prognosis in papillary thyroid carcinoma.
    Shen L; Qian C; Cao H; Wang Z; Luo T; Liang C
    World J Surg Oncol; 2018 Dec; 16(1):235. PubMed ID: 30558624
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Aldehyde dehydrogenase serves as a biomarker for worse survival profiles in ovarian cancer patients: an updated meta-analysis.
    Xia Y; Wei X; Gong H; Ni Y
    BMC Womens Health; 2018 Dec; 18(1):199. PubMed ID: 30522488
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The expression of death receptor systems TRAIL-R1/-R2/-R4, cd95 and TNF-R1 and their cognate ligands in pancreatic ductal adenocarcinoma.
    Gaertner F; Krüger S; Röder C; Trauzold A; Röcken C; Kalthoff H
    Histol Histopathol; 2019 May; 34(5):491-501. PubMed ID: 30375637
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Comprehensive Transcriptomic and Genomic Profiling of Subtypes of Follicular Variant of Papillary Thyroid Carcinoma.
    Song YS; Won JK; Yoo SK; Jung KC; Kim MJ; Kim SJ; Cho SW; Lee KE; Yi KH; Seo JS; Park YJ
    Thyroid; 2018 Nov; 28(11):1468-1478. PubMed ID: 30226444
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.